Home » Topics » Disease categories and therapies » Immune

Immune
RSS

NDA planned for orBec in iGVHD

April 22, 2005

Novel agents claimed for transplant rejection and immunological disorders

April 15, 2005

Intercell and Biological E sign Asia agreement for Japanese encephalitis vaccine

April 13, 2005

Good PK profile reported for sublingual tacrolimus after lung transplantation

April 11, 2005

Novel monoclonal antibodies imparted by Biogen Idec for use in immunosuppression

April 8, 2005

Dendritic cell-targeted immunosuppressive actions of JM-34

April 7, 2005

Sanofi pasteur's new polio vaccine licensed for use

April 5, 2005

Novel immunomodulatory agents disclosed by CNRS and INSERM

April 4, 2005

Immunosuppressant agents reported by Poseidon Pharmaceuticals

March 30, 2005

ACE BioSciences and SynCo collaborate on GMP production of ACE-393

March 29, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...